eye103
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jun 12, 2023 (NCT05919693)
Timeline
Indications
Mechanism of action
- Protein Wnt-3aAGONIST
WNT3A agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07205887 | Phase 2 | Sep 12, 2025 | EyeBiotech Ltd. |
| NCT06957080 | Phase 2/Phase 3 (Phase 3) | Apr 16, 2025 | EyeBiotech Ltd. |
| NCT06571045 | Phase 2/Phase 3 (Phase 3) | Aug 14, 2024 | EyeBiotech Ltd. |
| NCT05919693 | Phase 1/Phase 2 (Phase 2) | Jun 12, 2023 | EyeBiotech Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EyeBiotech Ltd. | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1